Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.895 USD | -3.56% | -5.25% | -48.64% |
07:57pm | Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial | MT |
02:04pm | Top Premarket Gainers | MT |
- Stock Market
- Equities
- BRNS Stock
- News Barinthus Biotherapeutics plc
- MarketScreener Strategies